Navinta Llc, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Apothecon- Your trusted partner for APIs & HPAPIs// Emerging leader in therapeutic generic drugs.
One of their notable products is BENZTROPINE MESYLATE USP, with a corresponding US DMF Number 32136.
Remarkably, this DMF maintains an Active status since its submission on February 09, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 29, 2018, and payment made on October 11, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II